T cell epitope-containing peptides of the major dog allergen can f 1 as candidates for allergen immunotherapy

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3614-3620

  Immonen, Anu ^a   Farci, Sandrine ^b   Taivainen, Antti ^c   Partanen, Jukka ^d   Pouvelle Moratille, Sandra ^b   Närvänen, Ale ^a   Kinnunen, Tuure ^a   Saarelainen, Soili ^a   Rytkönen Nissinen, Marja ^a   Maillere, Bernard ^b   Virtanen, Tuomas ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b CEA SACLAY   (France)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BOS D 2 ALLERGEN; CAN F 1 ALLERGEN; EPITOPE; HLA DR ANTIGEN; PEPTIDE; RAT N 1 ALLERGEN; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CAUCASIAN; CELL CLONE; CELL LINE; CLINICAL ARTICLE; DOG; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 24744445353     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3614     Document Type: Article

References (51)

1. Bousquet, J., R. Lockey, and H. J. Malling. 1998. Allergen immunotherapy: therapeutic vaccines for allergic diseases: a WHO position paper. J. Allergy Clin. Immunol. 102: 558-562.
2. Till, S. J., J. N. Francis, K. Nouri-Aria, and S. R. Durham. 2004. Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113: 1025-1034; quiz 1035.
3. Hardy, C. L., J. M. Rolland, and R. E. O'Hehir. 2004. Blocking antibodies in allergen immunotherapy: the Yin and Yang. Clin. Exp. Allergy 34: 510-512.
4. Briner, T. J., M. C. Kuo, K. M. Keating, B. L. Rogers, and J. L. Greenstein. 1993. Peripheral T cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc. Natl. Acad. Sci. USA 90: 7608-7612.
5. Hoyne, G. F., R. E. O'Hehir, D. C. Wraith, W. R. Thomas, and J. R. Lamb. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178: 1783-1788.
6. Oldfield, W. L., A. B. Kay, and M. Larche. 2001. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J. Immunol. 167: 1734-1739.
7. Oldfield, W. L., M. Larche, and A. B. Kay. 2002. Effect of T cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360: 47-53.
8. Norman, P. S., J. L. Ohman Jr., A. A. Long, P. S. Creticos, M. A. Gefter, Z. Shaked, R. A. Wood, P. A. Eggleston, K. B. Hafner, P. Rao, et al. 1996. Treatment of cat allergy with T cell reactive peptides. Am. J. Respir. Crit. Care Med. 154: 1623-1628.
9. Pene, J., A. Desroches, L. Paradis, B. Lebel, M. Farce, C. F. Nicodemus, H. Yssel, and J. Bousquet. 1998. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J. Allergy Clin. Immunol. 102: 571-578.
10. Kinnunen, T., C. Buhot, A. Närvänen, M. Rytkönen-Nissinen, S. Saarelainen, S. Pouvelle-Moratille, J. Rautiainen, A. Taivainen, B. Maillere, R. Mäntyjärvi, and T. Virtanen. 2003. The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells. Eur. J. Immunol. 33: 1717-1726.
11. Hartemann-Heurtier, A., L. T. Mars, N. Bercovici, S. Desbois, C. Cambouris, E. Piaggio, J. Zappulla, A. Saoudi, and R. S. Liblau. 2004. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes. J. Immunol. 172: 915-922.
12. Saarelainen, S., A. Taivainen, M. Rytkönen-Nissinen, S. Auriola, A. Immonen, R. Mäntyjärvi, J. Rautiainen, T. Kinnunen, and T. Virtanen. 2004. Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy. Clin. Exp. Allergy 34: 1576-1582.
13. Zeiler, T., R. Mäntyjärvi, J. Rautiainen, M. Rytkönen-Nissinen, P. Vilja, A. Taivainen, J. Kauppinen, and T. Virtanen. 1999. T cell epitopes of a lipocalin allergen colocalize with the conserved regions of the molecule. J. Immunol. 162: 1415-1422.
14. Texier, C., S. Pouvelle, M. Busson, M. Herve, D. Charron, A. Menez, and B. Maillere. 2000. HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 164: 3177-3184.
15. Texier, C., S. Pouvelle-Moratille, M. Busson, D. Charron, A. Menez, and B. Maillere. 2001. Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules. Eur. J. Immunol. 31: 1837-1846.
16. Castelli, F. A., C. Buhot, A. Sanson, H. Zarour, S. Pouvelle-Moratille, C. Nonn, H. Gahery-Segard, J. G. Guillet, A. Menez, B. Georges, and B. Maillere. 2002. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J. Immunol. 169: 6928-6934.
17. Konieczny, A., J. P. Morgenstern, C. B. Bizinkauskas, C. H. Lilley, A. W. Brauer, J. F. Bond, R. C. Aalberse, B. P. Wallner, and M. T. Kasaian. 1997. The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms. Immunology 92: 577-586.
18. Mäntyjärvi, R., S. Parkkinen, M. Rytkönen, J. Pentikäinen, J. Pelkonen, J. Rautiainen, T. Zeiler, and T. Virtanen. 1996. Complementary DNA cloning of the predominant allergen of bovine dander: a new member in the lipocalin family. J. Allergy Clin. Immunol. 97: 1297-1303.
19. Falquet, L., M. Pagni, P. Bucher, N. Hulo, C. J. Sigrist, K. Hofmann, and A. Bairoch. 2002. The PROSITE database, its status in 2002. Nucleic Acids Res. 30: 235-238.
20. Singh, H., and G. P. Raghava. 2001. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17: 1236-1237.
21. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
22. Kinnunen, T., A. Taivainen, J. Partanen, A. Immonen, S. Saarelainen, M. Rytkönen-Nissinen, J. Rautiainen, and T. Virtanen. 2005. The DR4-DQ8 haplotype and a specific T cell receptor Vb T cell subset are associated with absence of allergy to Can f 1. Clin. Exp. Allergy 35: 797-803.
23. Jeal, H., A. Draper, J. Harris, A. N. Taylor, P. Cullinan, and M. Jones. 2004. Determination of the T cell epitopes of the lipocalin allergen, Rat n 1. Clin. Exp. Allergy 34: 1919-1925.
24. Inoue, R., S. Matsushita, H. Kaneko, S. Shihoda, H. Sakaguchi, Y. Nishimura, and N. Kondo. 2001. Identification of β-lactoglobulin-derived peptides and class II HLA molecules recognized by T cells from patients with milk allergy. Clin. Exp. Allergy 31: 1126-1134.
25. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
26. Sturniolo, T., E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, and J. Hammer. 1999. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17: 555-561.
27. Mäntyjärvi, R., J. Rautiainen, and T. Virtanen. 2000. Lipocalins as allergens. Biochim. Biophys. Acta 1482: 308-317.
28. Kaiser, L., H. Gronlund, T. Sandalova, H. G. Ljunggren, M. van Hage-Hamsten, A. Achour, and G. Schneider. 2003. The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J. Biol. Chem. 278: 37730-37735.
29. Piastre, M., A. Stabile, G. Fioravanti, M. Castagnola, G. Pani, and F. Ria. 1994. Cord blood mononuclear cell responsiveness to β-lactoglobulin: T cell activity in "atopy-prone" and "non-atopy-prone" newborns. Int. Arch. Allergy Immunol. 104: 358-365.
30. Sakaguchi, H., R. Inoue, H. Kaneko, M. Watanabe, K. Suzuki, Z. Kato, S. Matsushita, and N. Kondo. 2002. Interaction among human leucocyte antigen-peptide-T cell receptor complexes in cow's milk allergy: the significance of human leucocyte antigen and T cell receptor-complementarity determining region 3 loops. Clin. Exp. Allergy 32: 762-770.
31. Virtanen, T., and R. Mäntyjärvi. 2004. Mammalian allergens. In Allergens and Allergen Immunotherapy, 3rd Ed. R. F. Lockey, S. C. Bukantz, and J. Bousquet eds. Marcel Dekker, New York, p. 297-317.
32. Flower, D. R., A. C. North, and C. E. Sansom. 2000. The lipocalin protein family: structural and sequence overview. Biochim. Biophys. Acta 1482: 9.
33. Virtanen, T., T. Zeiler, J. Rautiainen, and R. Mäntyjärvi. 1999. Allergy to lipocalins: a consequence of misguided T cell recognition of self and nonself? Immunol. Today 20: 398-400.
34. Saarelainen, S., T. Zeiler, J. Rautiainen, A. Närvänen, M. Rytkönen-Nissinen, R. Mäntyjärvi, P. Vilja, and T. Virtanen. 2002. Lipocalin allergen Bos d 2 is a weak immunogen. Int. Immunol. 14: 401-409.
35. van Neerven, R. J., C. Ebner, H. Yssel, M. L. Kapsenberg, and J. R. Lamb. 1996. T cell responses to allergens: epitope-specificity and clinical relevance. Immunol. Today 17: 526-532.
36. Ebner, C., S. Schenk, N. Najafian, U. Siemann, R. Steiner, G. W. Fischer, K. Hoffmann, Z. Szepfalusi, O. Scheiner, and D. Kraft. 1995. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J. Immunol. 154: 1932-1940.
37. Cardaba, B., V. Del Pozo, A. Jurado, S. Gallardo, I. Cortegano, I. Arrieta, A. Del Amo, P. Tramon, F. Florido, J. Sastre, P. Palomino, and C. Lahoz. 1998. Olive pollen allergy: searching for immunodominant T cell epitopes on the Ole e 1 molecule. Clin. Exp. Allergy 28: 413-422.
38. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569-1574.
39. Janssen, E. M., A. J. van Oosterhout, A. J. van Rensen, W. van Eden, F. P. Nijkamp, and M. H. Wauben. 2000. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J. Immunol. 164: 580-588.
40. + T cells. J. Immunol. 168: 3825-3832.
41. Joshi, S. K., P. R. Suresh, and V. S. Chauhan. 2001. Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology. J. Immunol. 166: 6693-6703.
42. de Lalla, C., T. Sturniolo, L. Abbruzzese, J. Hammer, A. Sidoli, F. Sinigaglia, and P. Panina-Bordignon. 1999. Cutting edge: identification of novel T cell epitopes in Lol p5a by computational prediction. J. Immunol. 163: 1725-1729.
43. Sone, T., K. Morikubo, M. Miyahara, N. Komiyama, K. Shimizu, H. Tsunoo, and K. Kino. 1998. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. J. Immunol. 161: 448-457.
44. Carballido, J. M., N. Carballido-Perrig, M. K. Kagi, R. H. Meloen, B. Wuthrich, C. H. Heusser, and K. Blaser. 1993. T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J. Immunol. 150: 3582-3591.
45. Counsell, C. M., J. F. Bond, J. L. Ohman Jr., J. L. Greenstein, and R. D. Garman. 1996. Definition of the human T cell epitopes of Pel d 1, the major allergen of the domestic cat. J. Allergy Clin. Immunol. 98: 884-894.
46. Schaeffer, E. B., A. Sette, D. L. Johnson, M. C. Bekoff, J. A. Smith, H. M. Grey, and S. Buus. 1989. Relative contribution of "determinant selection" and "holes in the T cell repertoire" to T ell responses. Proc. Natl. Acad. Sci. USA 86: 4649-4653.
47. Kedl, R. M., J. W. Kappler, and P. Marrack. 2003. Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 15: 120-127.
48. Demotz, S., P. M. Matricardi, C. Irle, P. Panina, A. Lanzavecchia, and G. Corradin. 1989. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways. J. Immunol. 143: 3881-3886.
49. Nikcevich, K. M., D. Kopielski, and A. Finnegan. 1994. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo. J. Immunol. 153: 1015-1026.
50. Wang, Y., J. A. Smith, M. L. Gefter, and D. L. Perkins. 1992. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes. J. Immunol. 148: 3034-3041.
51. Clayton, J., C. Lonjou, and D. Whittle. 1997. Allele and haplotype frequencies for HLA loci in various ethnic groups. In Genetic Diversity of HLA Functional and Medical Implication, Vol. 1. D. Charron ed. EDK, Paris, p. 665-820.